119th Congress · introduced in the House · Sep 15, 2025
Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
Official title from Congress.gov
Latest action (Sep 18, 2025): Sponsor introductory remarks on measure. (CR H4418)
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Sponsor introductory remarks on measure. (CR H4418)
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
4 citations.
AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES · lobbying firm or registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
Cure Hepatitis C Act of 2025, S 1941; The Ian Kalvinkas Pediatric Liver Cancer Early Detection and Screening Act, HR 5355
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES · lobbying firm or registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
Cure Hepatitis C Act of 2025, S 1941; The Ian Kalvinkas Pediatric Liver Cancer Early Detection and Screening Act, HR 5355
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES · lobbying firm or registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…Hepatitis C Act of 2025, S 1941; The Advisory Committee on Immunization Practices; THe Ian Kalvinkas Pediatric Liver Cancer Early Detection and Screening Act, HR 5355
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
VALLEY CHILDREN'S HEALTHCARE · lobbying firm or registrant: BROWNSTEIN HYATT FARBER SCHRECK, LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 16, 2025 · issue area: Health Issues
$30,000
Paid to lobbying firm
…National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing